Presentation

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

REGISTER for free or LOG IN to view this content

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Coronary

Presentation

Cell Therapy 2013

Up Next

Presentation

Multimodality Imaging: Enhancing Outcomes with Available Technology

Presenter: Amish Raval

January 22, 2013

More slides +

Presentation

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.